Virtu Financial’s Bionano Genomics BNGO Stock Holding History

Virtu Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16K	Buy	+13,751	New	+$17.6K	﹤0.01%	1419
2024 Q2	–	Sell	-548	Closed	-$36K	–	1337
2024 Q1	$36K	Buy	+548	New	+$40.9K	﹤0.01%	1074
2023 Q3	–	Sell	-397	Closed	-$145K	–	1335
2023 Q2	$145K	Buy	397 +299	+305%	+$135K	0.01%	916
2023 Q1	$65K	Sell	98 -333	-77%	-$296K	0.01%	1056
2022 Q4	$378K	Buy	431 +323	+299%	+$406K	0.05%	378
2022 Q3	$119K	Buy	+108	New	+$143K	0.01%	1040
2021 Q4	–	Sell	-165	Closed	-$544K	–	1726
2021 Q3	$544K	Sell	165 -352	-68%	-$1.23M	0.05%	426
2021 Q2	$2.27M	Buy	+517	New	+$2.04M	0.22%	61
2020 Q4	–	Sell	-421	Closed	-$164K	–	1450
2020 Q3	$164K	Buy	+421	New	+$163K	0.03%	628
2019 Q4	$75K	Buy	102 +69	+209%	+$40.3K	0.01%	1136
2019 Q3	$14K	Buy	+33	New	+$35.9K	﹤0.01%	1321

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CAM

Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

EGM

Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Virtu Financial's BNGO Position: Q1 2026 in Review

Virtu Financial opened a new position in Bionano Genomics (BNGO) in Q1 2026: 13,751 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #1419 among its holdings. This is a return to the name: Virtu Financial previously reported a position in BNGO as recently as Q1 2024.

Virtu Financial first reported a position in BNGO in Q3 2019 and has held it in 11 quarters since. The position peaked at $2.27M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

Virtu Financial held 13,751 shares of Bionano Genomics worth $16K as of Q1 2026.
Bionano Genomics was a new Virtu Financial position in Q1 2026.
Bionano Genomics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1419 holding.
Virtu Financial first reported a position in Bionano Genomics in Q3 2019 and has held it in 11 quarters since.
Virtu Financial's Bionano Genomics position peaked at $2.27M in Q2 2021.
32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.